AI can speed up drug discovery and decrease attrition rates in the clinic, but it is important to recognize that both are tall orders. The companies that will benefit most are those that stay grounded, set realistic expectations, and keep experienced scientists at the center of decisions that require genuine creativity and judgment. The post AI in Drug Discovery: Surveying the Breadth of the Challenges appeared first on MedCity News .
[Sponsored] A checklist for AI readiness from Nordic aims to help healthcare organizations avoid failure. The post Is Your Healthcare Organization Ready to Implement AI? appeared first on MedCity News .
There is an effective vaccine for Ebola — but not for the variety spreading rapidly in the Democratic Republic of Congo. Trials are going on for several candidates. How long will it take?
(MedPage Today) -- Note that some links may require registration or subscription. President Trump took finasteride (Propecia) during his first term in office, according to several of his past physicians, but the hair-loss drug has not appeared...
(MedPage Today) -- An established blood thinner regimen failed to extend its cardioprotective benefits to patients with advanced chronic kidney disease (CKD), according to the international TRACK trial. In this placebo-controlled study of patients...
Thyme Care has expanded its cancer survivorship program, called Next Chapter Care, to provide a personalized, longitudinal approach to survivorship support.